Latest Biotech News

Leica Biosystems expanded a computational pathology collaboration with AstraZeneca and Daiichi Sankyo, building an end-to-end research workflow to quantify the TROP2 Normalized Membrane Ratio...

Hartwig Medical Foundation expanded its partnership with Ultima Genomics by adopting the Ultima UG200 sequencing platform to scale whole-genome-informed ctDNA monitoring. The partners said the...

T-Curx received Swissmedic clinical trial approval for its nonviral, Siglec-6-targeted CAR T program TCX-001, clearing a first-in-human phase I study in Switzerland. The company said it plans to...

Ethyreal launched with $101 million across venture rounds to develop a long-acting anti-TSHR monoclonal antibody, ETHY-001, for Graves’ disease and thyroid eye disease. The company disclosed...

Caribou linked its off-the-shelf CAR-T lymphoma program to updated efficacy evidence, reporting a 17.1-month median progression-free survival. The company said the data add to the rationale that...

Camurus received another complete response letter from the FDA for its monthly subcutaneous extended-release acromegaly drug CAM-2029, which is expected to be branded Oclaiz in the U.S. The...

Enliven Therapeutics shared updated early data for ELVN-001 in previously treated chronic myeloid leukemia (CML), with results discussed for a proposed go-forward 80 mg once-daily cohort. The...

A Chinese research team reported safety and feasibility for a subretinal gene therapy delivering an AAV8 vector carrying RS1 in pediatric X-linked retinoschisis, publishing in the New England...

Prometheus raised $12 billion to build “artificial general engineers” aimed at accelerating biopharma workflows, according to a STAT+ report on the company’s capital push. The fundraising...

Roche’s Foundation Medicine rebranded Saga Diagnostics’ minimal residual disease (MRD) platform following the company’s $595 million Saga acquisition earlier this year, positioning the test for...

Guardant Health said the FDA approved its Guardant360 CDx as a companion diagnostic for Boehringer Ingelheim’s Hernexeos (zongertinib) in HER2-mutant advanced non-small cell lung cancer. The...

Prometheus, an AI “clinical engineering” startup, raised $12 billion to build “artificial general engineers” and expand use cases across biopharma workflows, including trial operations. The...

SonoThera secured an oversubscribed $125 million Series B to move its ultrasound-mediated genetic medicine platform into clinical development. The company framed the round as funding for two lead...

Parabilis priced an upsized IPO at $20 per share, raising $670 million—setting a new record for venture-backed biopharma listings. The company sold 3.5 million shares in the offering and said...

Camurus received a second complete response letter (CRL) from the FDA for its subcutaneous extended-release acromegaly drug CAM-2029 (Oclaiz in the U.S.), with the rejection tied to issues at a...

China’s National Medical Products Administration approved Suzhou Alphamab’s HER2 bispecific antibody anbenitamab (KN-026) for adults with locally advanced or metastatic HER2-positive gastric and...

Grail shareholders filed a class action lawsuit in the U.S. District Court for the Northern District of California accusing Grail and executives of making false and misleading statements about the...

Enliven Therapeutics updated early phase I results for ELVN-001 in chronic myeloid leukemia (CML), with the company’s proposed go-forward 80-mg cohort showing major molecular response increasing...

Hartwig Medical Foundation expanded its partnership with Ultima Genomics by adopting the Ultima UG200 sequencing platform to increase sequencing scale and throughput while lowering overall costs...

Biotech IPO activity stayed hot as Parabilis Medicines priced an upsized $670 million offering, underscoring investor willingness to back later-stage oncology developers with credible cash plans....